Results from the MITHRAS trial reported at TCT Connect and published in Circulation

(Cardiovascular Research Foundation) The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six-minute walking distance.

https://www.eurekalert.org/pub_releases/2020-10/crf-rft_1101520.php

Source: EurekAlert! - Medicine and Health - October 15, 2020 Category: International Medicine & Public Health Source Type: news